Changsha Mind Decode Technology Co., Ltd.

Founded in 2024 and based in Changsha, China, Changsha Mind Decode Technology Co. , Ltd. develops neurodiagnostic software that combines statistical analysis and deep learning to enhance clinical EEG interpretation. The company built the EEG-X platform, which identifies seizure-related signals, localizes suspected lesion regions, detects abnormal discharges and generates automated EEG reports.

In November 2025, the firm closed a round of series A funding. The company works with hospitals, clinics and EEG equipment providers to deliver the EEG-X intelligent EEG analysis platform, supporting automated seizure detection, spike identification, lesion-suggestion output and EEG report generation. The company’s revenue is generated through institutional software licensing and cloud-based EEG analysis services. The company will use the series A funding to advance development of the EEG-X platform, strengthen AI models for neurological diagnostics and accelerate clinical deployment and commercialization of its neurotechnology solutions.